SCHEMBL12406

SCHEMBL12406

c1cnc2nnccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MMP2 P08253 2/20 0.42
TSHR P16473 2/20 0.42
CYP3A4 P08684 2/20 0.42
HTT P42858 2/20 0.42
GMNN O75496 1/20 0.42
TP53 P04637 1/20 0.42
HSP90AA1 P07900 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
MMP9 P14780 1/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
MMP8 P22894 1/20 0.42
CCR1 P32246 1/20 0.42
THPO P40225 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29600604 1.00 ALDH1A1 (0.44) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL31254127 1.00 ALDH1A1 (0.44) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL29047204 0.82 ALDH1A1 (0.33) ALDH1A1KDM4ELMNAMEN1KMT2A
Benzofuran SCHEMBL29153281 0.81 KDM4E (0.36) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL28304525 0.79 CCR1 (0.55) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL8193 0.79 CCR1 (0.55) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL29354893 0.79 CCR1 (0.55) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL30323275 0.79
Ammonia Solution, Strong SCHEMBL2732606 0.76 CCR1 (0.52) ALDH1A1KDM4ELMNAMEN1KMT2A
Hydrochloric Acid SCHEMBL16337846 0.76 CCR1 (0.52) ALDH1A1KDM4ELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119212430-A Light emitting device and electronic apparatus including the same 三星电子株式会社 2024-12-27 CN claimed
WO-2021083186-A1 PIPERIDINAMINE COMPOUND CONTAINING FUSED RING PYRIMIDINE, PREPARATION METHOD THEREFOR AND USE THEREOF 沈阳中化农药化工研发有限公司 2021-05-06 WO claimed
US-20150011569-A1 NOVEL P13K p110 INHIBITORS AND METHODS OF USE THEREOF DREXEL UNIVERSITY 2015-01-08 US claimed
WO-2013090725-A1 NOVEL PI3K p110 INHIBITORS AND METHODS OF USE THEREOF PHILADELPHIA HEALTH & EDUCATION CORPORATION (US) 2013-06-20 WO claimed
EP-2558462-A1 PYRIDYL-VINYL PYRAZOLOQUINOLINES AS PAR1 INHIBITORS SANOFI (FR) 2013-02-20 EP claimed
US-20130040981-A1 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors SANOFI (FR) 2013-02-14 US claimed
WO-2011128420-A1 PYRIDYL-VINYL PYRAZOLOQUINOLINES AS PAR1 INHIBITORS SANOFI (FR) 2011-10-20 WO claimed
CN-119684328-A Condensed-cyclic compound, light-emitting device including the same, and electronic apparatus including the light-emitting device 三星电子株式会社 2025-03-25 CN disclosed
CN-119431415-A Condensed-cyclic compound, light-emitting device including the same, and electronic apparatus including the light-emitting device 三星电子株式会社 2025-02-14 CN disclosed
CN-119212430-A Light emitting device and electronic apparatus including the same 三星电子株式会社 2024-12-27 CN disclosed
CN-118994214-A Condensed polycyclic compound, light-emitting device including the same, and electronic apparatus including the light-emitting device 三星电子株式会社 2024-11-22 CN disclosed
CN-118360050-A Composition, light-emitting device including the same, and electronic apparatus including the light-emitting device 三星电子株式会社 2024-07-19 CN disclosed
CN-118284092-A Light emitting device and electronic apparatus including the same 三星电子株式会社 2024-07-02 CN disclosed
US-6156766-A Benzamide compounds and pharmaceutical use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-12-05 US disclosed
EP-1034793-A1 PREVENTIVES/REMEDIES FOR GLAUCOMA Senju Pharmaceutical Co., Ltd. (JP) 2000-09-13 EP disclosed
EP-0641781-B1 4-AMINO(ALKYL)CYCLOHEXANE-1-CARBOXAMIDE COMPOUND AND USE THEREOF YOSHITOMI PHARMACEUTICAL (JP) 2000-07-26 EP disclosed
EP-0956865-A1 MEDICINES COMPRISING Rho KINASE INHIBITOR YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-11-17 EP disclosed
EP-0757038-A1 BENZAMIDE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-02-05 EP disclosed
US-5478838-A Treating hypertension, angina pectoris, asthma, improving peripheral circulation YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1995-12-26 US disclosed
EP-0641781-A1 4-AMINO(ALKYL)CYCLOHEXANE-1-CARBOXAMIDE COMPOUND AND USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1995-03-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040981-A1 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors F2R, F2RL1, F2RL3 ALDH1A1 1434/4885KDM4E 3015/4885LMNA 1494/4885
US-20150011569-A1 NOVEL P13K p110 INHIBITORS AND METHODS OF USE THEREOF PIK3R5, PIK3R4, PIK3CD ALDH1A1 4719/4885KDM4E 1356/4885LMNA 2231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.